Subtotal: ₨142.00
Marketed By: CCL Pharmaceuticals (Pvt) Ltd Therapeutic Segment: Anti-Epileptic Generic:Levetiracetam Indication: as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy.
as adjunctive therapy for the treatment of myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy. Product Form: Tablet Pack Size:10's
Weight | 250 g |
---|---|
Dimensions | 10 × 10 × 10 cm |
Click one of our contacts below to chat on WhatsApp